Thomas R Baruch's Net Worth
$28.1 Million
Who is Thomas R Baruch?
Thomas R Baruch has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include CODEXIS, INC., TETRAPHASE PHARMACEUTICALS INC, ENTROPIC COMMUNICATIONS INC, INTERMOLECULAR INC, Monogram Biosciences, Inc., PHYSIOMETRIX INC, SYMYX TECHNOLOGIES INC, ACLARA BIOSCIENCES INC, and NETRO CORP.
SEC CIK
Thomas R Baruch's CIK is 0001005563
Past Insider Trading and Trends
2007 was Thomas R Baruch's most active year for acquiring shares with 58 total transactions. Thomas R Baruch's most active month to acquire stocks was the month of November. 2007 was Thomas R Baruch's most active year for disposing of shares, totalling 56 transactions. Thomas R Baruch's most active month to dispose stocks was the month of November. 2013 saw Thomas R Baruch paying a total of $4,499,999.00 for 2,261,809 shares, this is the most they've acquired in one year. In 2010 Thomas R Baruch cashed out on 6,015,158 shares for a total of $19,650,814.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.00% | -4.95K |
$10.61 | -$52,464.42 | 33.09K |
Scheduled
|
Jun 12
| ||
Form 4
| -28.28% | -15.00K |
$10.70 | -$160,441.50 | 38.04K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| -27.38% | -20.00K |
$18.65 | -$372,906.00 | 53.04K |
Scheduled
|
Jan 15 - Jan 16
| ||
Form 4
| -32.40% | -35.00K |
$15.60 | -$546,127.75 | 73.04K |
Scheduled
|
Dec 10 - Dec 11
| ||
Form 4
| +4.80% | 4.95K |
—
|
—
| 108.04K |
Jun 11
| |||
Form 4
| -19.52% | -25.00K |
$16.03 | -$400,801.25 | 103.09K |
Scheduled
|
Dec 27 - Dec 28
| ||
Form 4
| -16.33% | -25.00K |
$18.54 | -$463,392.67 | 128.09K |
Scheduled
|
Sep 26 - Sep 27
| ||
Form 4
| -14.04% | -25.00K |
$14.93 | -$373,325.00 | 153.09K |
Scheduled
|
Jun 25 - Jun 26
| ||
Form 4
| +3.44% | 5.92K |
—
|
—
| 178.09K |
Jun 11
| |||
Form 4
| -12.68% | -25.00K |
$11.05 | -$276,317.50 | 172.17K |
Scheduled
|
Mar 28 - Mar 29
| ||
Form 4
| +9.98% | 17.89K |
—
|
—
| 197.17K |
Jun 14
| |||
Form 4
| +12.62% | 20.09K |
—
|
—
| 179.28K |
Jun 15
| |||
Form 4
| +14.97% | 20.73K |
—
|
—
| 159.18K |
Jun 10
| |||
Form 4
| -100.00% | -2.92M |
—
|
—
|
0
|
Nov 10
| |||
Form 4
| +70.89% | 57.43K |
—
|
—
| 138.45K |
Jun 11
| |||
Form 4
| +77.66% | 35.42K |
—
|
—
| 81.02K |
Jan 2
| |||
Form 4
| +1,724.12% | 43.1K |
—
|
—
| 45.6K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 2.5K |
$7.55 | $18,864.00 | 2.5K |
Aug 27
| |||
Form 4
|
∞
| 2.92M |
—
|
—
| 2.92M |
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.64% | -100.00K |
$10.20 | -$1,020,000.00 | 2.06M |
Sep 18
| |||
Form 4
| -2.42% | -53.47K |
$9.26 | -$495,108.00 | 2.16M |
Sep 16 - Sep 17
| |||
Form 4
| +93.43% | 2.21M |
$7.00 | $4,499,999.00 | 4.57M |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENTROPIC COMMUNICATIONS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -19.52% | -899.27K |
$9.21 | -$8,282,267.49 | 3.71M |
Feb 23
| |||
Form 4
| -24.48% | -1.49M |
$7.83 | -$11,669,033.34 | 4.6M |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| -19.80% | -1.50M |
$5.27 | -$7,927,260.48 | 6.09M |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4/A
| +27.68% | 7.52M |
$0.43 | $20,039.69 | 34.69M |
Dec 12
| |||
Form 4/A
| +27.68% | 7.52M |
$0.43 | $20,039.69 | 34.69M |
Dec 12
| |||
Form 4
| +27.69% | 7.52M |
$0.43 | $21,106.41 | 34.7M |
Dec 12
| |||
Form 4
| +27.69% | 7.52M |
$0.43 | $21,106.41 | 34.7M |
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERMOLECULAR INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +3,073.52% | 125K |
$1.50 | $187,500.00 | 129.07K |
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4/A
|
∞
| 4.07K |
—
|
—
| 4.07K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
∞
| 4.07K |
—
|
—
| 4.07K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
∞
| 7.55M |
—
|
—
| 7.55M |
Nov 23
| |||
Form 4
|
∞
| 7.55M |
—
|
—
| 7.55M |
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monogram Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||